Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

CHMP2B anticorps (AA 1-213)

Cet anticorps Lapin Polyclonal détecte spécifiquement CHMP2B dans ELISA et IHC. Il présente une réactivité envers Humain.
N° du produit ABIN7147523

Aperçu rapide pour CHMP2B anticorps (AA 1-213) (ABIN7147523)

Antigène

Voir toutes CHMP2B Anticorps
CHMP2B (Charged Multivesicular Body Protein 2B (CHMP2B))

Reactivité

  • 36
  • 33
  • 17
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Humain

Hôte

  • 47
  • 3
  • 2
Lapin

Clonalité

  • 46
  • 6
Polyclonal

Conjugué

  • 26
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp CHMP2B est non-conjugé

Application

  • 43
  • 15
  • 14
  • 13
  • 13
  • 8
  • 7
  • 5
  • 3
  • 3
  • 3
  • 1
  • 1
ELISA, Immunohistochemistry (IHC)
  • Épitope

    • 15
    • 9
    • 4
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    AA 1-213

     Réactivité croisée

    Humain

    Purification

    Antigen Affinity Purified

    Immunogène

    Recombinant Human Charged multivesicular body protein 2b protein (1-213AA)

    Isotype

    IgG
  • Indications d'application

    Recommended dilution: IHC:1:20-1:200,

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    -20 °C,-80 °C

    Stockage commentaire

    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Antigène

    CHMP2B (Charged Multivesicular Body Protein 2B (CHMP2B))

    Autre désignation

    CHMP2B

    Sujet

    Background: Probable core component of the endosomal sorting required for transport complex III (ESCRT-III) which is involved in multivesicular bodies (MVBs) formation and sorting of endosomal cargo proteins into MVBs. MVBs contain intraluminal vesicles (ILVs) that are generated by invagination and scission from the limiting membrane of the endosome and mostly are delivered to lysosomes enabling degradation of membrane proteins, such as stimulated growth factor receptors, lysosomal enzymes and lipids. The MVB pathway appears to require the sequential function of ESCRT-O, -I,-II and -III complexes. ESCRT-III proteins mostly dissociate from the invaginating membrane before the ILV is released. The ESCRT machinery also functions in topologically equivalent membrane fission events, such as the terminal stages of cytokinesis and the budding of enveloped viruses (HIV-1 and other lentiviruses). ESCRT-III proteins are believed to mediate the necessary vesicle extrusion and/or membrane fission activities, possibly in conjunction with the AAA ATPase VPS4.

    Aliases: ALS17 antibody, Charged multivesicular body protein 2b antibody, CHM2B_HUMAN antibody, CHMP family, member 2B antibody, CHMP2.5 antibody, CHMP2b antibody, Chromatin modifying protein 2b antibody, Chromatin-modifying protein 2b antibody, DMT1 antibody, hVps2-2 antibody, Vacuolar protein sorting 2, yeast, homolog of, B antibody, Vacuolar protein sorting 2-2 antibody, Vacuolar protein sorting-associated protein 2-2 antibody, VPS2 homolog B antibody, Vps2-2 antibody, VPS2B antibody

    UniProt

    Q9UQN3
Vous êtes ici:
Chat with us!